These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4903987)

  • 1. Comparisons of results of different patient evaluation methods in clinical psychopharmacology.
    Esser AH; Flegel H
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):292-5. PubMed ID: 4903987
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of therapeutic responsivity to thiothixene in schizophrenics.
    Sterlin C; Oliveros R; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):394-6. PubMed ID: 4882603
    [No Abstract]   [Full Text] [Related]  

  • 3. Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial.
    Vinar O; Formánková M; Taussigová D; Růzicka S
    Act Nerv Super (Praha); 1967 Nov; 9(4):353-5. PubMed ID: 4889058
    [No Abstract]   [Full Text] [Related]  

  • 4. Pimozide in chronic schizophrenic patients.
    Huber W; Serafetinides EA; Colmore JP; Clark M
    J Clin Pharmacol New Drugs; 1971; 11(4):304-9. PubMed ID: 4932748
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use and abuse of rating scales and statistics in psychopharmacology].
    Hamilton M
    Acta Psychiatr Belg; 1983; 83(2):155-62. PubMed ID: 6353868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
    Cocito E; Ambrosini G; Arata A; Bevilacqua P; Tortora E
    Arzneimittelforschung; 1970 Aug; 20(8):1119-25. PubMed ID: 4921409
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative value of rating and self-rating scales in drug trials [proceedings].
    Kellner R; Sheffield BF; Simpson GM
    Psychopharmacol Bull; 1977 Apr; 13(2):12-4. PubMed ID: 323904
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia.
    Tibbo P; Swainson J; Chue P; LeMelledo JM
    Depress Anxiety; 2003; 17(2):65-72. PubMed ID: 12621594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
    Laenen A; Alonso A; Molenberghs G; Vangeneugden T; Mallinckrodt CH
    J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prazepam in anxiety: a controlled clinical trial [proceedings].
    Rickels K; Downing RW
    Psychopharmacol Bull; 1977 Apr; 13(2):19-21. PubMed ID: 323905
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical comparison of molindone hydrochloride with trifluoperazine in psychotic outpatients.
    Brauzer B; Goldstein BJ
    Curr Ther Res Clin Exp; 1971 Mar; 13(3):152-7. PubMed ID: 4998285
    [No Abstract]   [Full Text] [Related]  

  • 12. Delusions of infestation treated by pimozide: a double-blind crossover clinical study.
    Hamann K; Avnstorp C
    Acta Derm Venereol; 1982; 62(1):55-8. PubMed ID: 6175138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rating scales and assessment instruments for use in pediatric psychopharmacology research.
    Psychopharmacol Bull; 1985; 21(4):714-1124. PubMed ID: 3911249
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical evaluation of clopenthixol.
    Yaryura-Tobias JA; Wolpert A; White L; Agola P; Merlis S
    Curr Ther Res Clin Exp; 1970 May; 12(5):271-9. PubMed ID: 4986242
    [No Abstract]   [Full Text] [Related]  

  • 15. Methodological considerations in evaluating antianxiety drugs.
    Hollister LE
    J Clin Pharmacol J New Drugs; 1970; 10(1):12-8. PubMed ID: 4903952
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of a new psychotropic drug--molindone.
    Ramsay RA; Lehmann HE; Ban TA; Saxena BM; Bennett J
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):46-8. PubMed ID: 4909378
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors which can make patients difficult to treat.
    Kane JM
    Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650
    [No Abstract]   [Full Text] [Related]  

  • 18. Metiapine: a double-blind evaluation in chronic schizophrenic patients.
    Gallant DM; Bishop MP; Guerrero-Figueroa R
    Curr Ther Res Clin Exp; 1971 Dec; 13(12):734-6. PubMed ID: 5001741
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical experience with octoclothepin in psychoses. Comparasion with perphenazine.
    Náhunek K; Svestka J; Rodová A
    Act Nerv Super (Praha); 1968 Oct; 10(3):339-40. PubMed ID: 4883242
    [No Abstract]   [Full Text] [Related]  

  • 20. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.